Takeda Pharmaceutical Co Ltd (4502.T)
14 Dec 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|76||2017||Independent Chairman of the Executive Board|
|50||2015||President, Chief Executive Officer, Representative Director|
|52||2015||Chief Medical & Scientific Officer, Director|
|58||2015||President of Japan Pharma Business Unit, Director|
- Bumper crop of new drugs fails to lift big pharma R&D returns
- U.S. study sheds light on how Zika causes nerve disorder
- UPDATE 1-Amgen's Kyprolis improves overall survival in blood cancer patients
- UPDATE 3-Sage shares surge as depression drug succeeds in mid-stage trial
- BRIEF-Obsidian Therapeutics Announces $49.5 Mln Series A Financing To Develop Controllable Cell And Gene Therapy Products